Log in to save to my catalogue

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of...

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4692fc6d59e94fcf9a8e55f71a6ef080

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer

About this item

Full title

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer

Publisher

Switzerland: MDPI AG

Journal title

Diagnostics (Basel), 2024-11, Vol.14 (22), p.2501

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Bladder cancer (BC) is a highly heterogeneous disease, presenting clinical challenges, particularly in predicting patient outcomes and selecting effective treatments. Molecular subtyping has emerged as an essential tool for understanding the biological diversity of BC; however, its implementation in clinical practice remains limited due to the high...

Alternative Titles

Full title

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4692fc6d59e94fcf9a8e55f71a6ef080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4692fc6d59e94fcf9a8e55f71a6ef080

Other Identifiers

ISSN

2075-4418

E-ISSN

2075-4418

DOI

10.3390/diagnostics14222501

How to access this item